Evidence map›Paper›PMID 35784626›Full record

ArticleAnnals of gastroenterology

Endoscopic submucosal dissection for early esophagogastric junction adenocarcinomas: a systematic review.

Paul Doumbe-Mandengue, Anna Pellat, Benoit Terris, Frédéric Beuvon, Mahaut Leconte, Anthony Dohan, Stanislas Chaussade, Romain Coriat, Maximilien Barret

Open access · diamondAbstract read
In one paragraph

Article in Annals of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Paul Doumbe-MandengueDepartment of Gastroenterology and Digestive Oncology, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (Paul Doumbe-Mandengue, Anna Pellat, Stanislas Chaussade, Romain Coriat, Maximilien Barret).
Anna PellatDepartment of Gastroenterology and Digestive Oncology, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (Paul Doumbe-Mandengue, Anna Pellat, Stanislas Chaussade, Romain Coriat, Maximilien Barret).
Benoit TerrisDepartment of Medicine, Université de Paris (Anna Pellat, Benoit Terris, Anthony Dohan, Stanislas Chaussade, Romain Coriat, Maximilien Barret).
Frédéric BeuvonDepartment of Pathology, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (Benoit Terris, Frédéric Beuvon).
Mahaut LeconteDepartment of Digestive Surgery, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (Mahaut Leconte).
Anthony DohanDepartment of Medicine, Université de Paris (Anna Pellat, Benoit Terris, Anthony Dohan, Stanislas Chaussade, Romain Coriat, Maximilien Barret).
Stanislas ChaussadeDepartment of Gastroenterology and Digestive Oncology, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (Paul Doumbe-Mandengue, Anna Pellat, Stanislas Chaussade, Romain Coriat, Maximilien Barret).
Romain CoriatDepartment of Gastroenterology and Digestive Oncology, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (Paul Doumbe-Mandengue, Anna Pellat, Stanislas Chaussade, Romain Coriat, Maximilien Barret).
Maximilien BarretDepartment of Gastroenterology and Digestive Oncology, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (Paul Doumbe-Mandengue, Anna Pellat, Stanislas Chaussade, Romain Coriat, Maximilien Barret).
Assistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Esophagogastric junction adenocarcinomas (EGJAs) include esophageal and gastric cardia adenocarcinomas (GCAs). These tumors are currently regarded as a single entity, with similar surgical and oncological therapies, although they originate from different organs. Endoscopy allows an early-stage diagnosis, where both subtypes can be differentiated. With this review we aimed to describe the outcomes of endoscopic submucosal dissection for the treatment of esophageal adenocarcinomas (EAs) and GCAs. Methods: We identified studies by screening PubMed, Embase and Web of Science. We included all 19 studies that mentioned at least one of the following criteria of interest: Results: We found an Conclusions: Endoscopic submucosal dissection is safe and effective for esophageal and GCAs. These data support the extension of the use of endoscopic submucosal dissection to all EGJAs, including early EAs.

Indexed as

Barrett’s adenocarcinomaendoscopic submucosal dissectionEsophagogastric junction adenocarcinomagastric cardia adenocarcinoma

Identifiers

PMID35784626
PMCPMC9210784
OpenAlexW4283826819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.